Omeros saw the highest growth of 2.49% in patent filings in May and 2.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.28% and grants by 2.99%. GlobalData’s DataBook provides a comprehensive analysis of Omeros‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Omeros has been focused on protecting inventions in Israel(IL) with five publications in Q2 2024

The Israel(IL) Patent Office dominates the patent filings and grants with nearly 22% filings and 27% grants. The Israel(IL), China(CN), United States(US), and Australia(AU) patent Office are among the top ten patent offices where Omeros is filings its patents. Among the top granted patent authorities, Omeros has 36% of its grants in United States(US), 27% in Israel(IL) and 9% in Australia(AU).

Regeneron Pharmaceuticals and Roche could be the strongest competitors for Omeros

In terms of grant share, Omeros stands in third position among its competitors. Regeneron Pharmaceuticals and Roche secured the top positions according to recent patent publication data.

Patents related to climate change and rare diseases lead Omeros's portfolio

Omeros has the highest number of patents in climate change followed by, rare diseases and addiction. For climate change, nearly 60% of patents were filed and 14% of patents were granted in Q2 2024.

Injury related patents lead Omeros portfolio followed by parasitic diseases, and atypical hemolytic uremic syndrome (nondiarrhea - associated hemolytic uremic syndrome)

Omeros has highest number of patents in injury followed by parasitic diseases, atypical hemolytic uremic syndrome (nondiarrhea - associated hemolytic uremic syndrome), thrombosis, and cryopyrin-associated periodic syndromes. For injury, nearly 9% of patents were filed and 2% of patents were granted in Q2 2024.

For comprehensive analysis of Omeros's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.